Surgical Holdings has introduced the new NuTrace laser marking system to help hospitals ensure full traceability of surgical instruments in the sterile supply workflow.
The NuTrace NUX20ng Fiber Laser is the first laser in the world exclusively designed for the Sterile Processing Department, allowing them to quickly and inexpensively mark surgical instruments.
The system provides a fast, efficient, and accurate way to permanently mark surgical instruments with unique identifiers, helping to ensure that they are easily identifiable and traceable throughout their lifecycle.
It utilises state-of-the-art technology that ensures that the laser marking is clear, legible, and long-lasting, even after repeated sterilisation cycles.
The technology, which featuress a 1064 nm laser wavelength, enables users to mark instruments with precision and accuracy, minimising the risk of human error and enhancing the quality of care for patients.
It works by creating readable datamatrix codes, a 2D barcode embedded into each instrument, ensuring they have a unique identification.
The system further utilises Ratero – a unique chemical that is used to treat the instruments after laser marking, to remove the risk of corrosion from free iron after marking, which presents as a common issue for many laser markers.
The NuTrace Laser Marker is user-friendly and can be easily integrated into existing workflows, making it a valuable addition to any sterile services department.
The solution allows items to be tracked ensuring positive identification throughout the washing, disinfection, packing and sterilisation process in Hospital Decontamination Units.
Dan Coole, Managing Director of Surgical Holdings, said:
“The migration of surgical instruments in healthcare is a well-known problem.
“It is extremely difficult to determine which instrument belongs where, or which instrument goes to a set when they all look alike.
“With traceability becoming increasingly paramount, NuTrace offers the best option for today’s surgical suites and Sterile Services Departments.
“This is peace of mind for patients, as instruments can then be easily tracked through the hospital.
“We are excited to be introducing this ground-breaking technology as a new service for our customers in the UK & Ireland.”
Being able to ensure full traceability of devices and to comply with the new unique device identification (UDI) regulatory requirements is a priority for hospitals.
Complementing the technology, the Nutrace R+ Max Healthcare advanced 2D DataMatrix reader has been specifically designed to read the most challenging 2D datamatrix codes, all types of surgical instruments and implants in the fastest time possible.
Together offering a full, turnkey solutions for hospitals.
Surgical Holdings is committed to providing high-quality surgical instruments and medical equipment to healthcare professionals across the globe.
The NuTrace NUX20ng Fiber Laser and Nutrace R+ Max 2D Data Matrix Reader are the latest additions to its portfolio of innovative products, and available for distribution throughout the UK & Ireland.
AI helps cut nuisance alerts for healthcare teams
Stabilising the NHS – it’s going to take a lot more than AI
Answer Digital enables speedy deployment of AI with strategic partnerships
Transforming NHS procurement: How good data holds the key to integrated care
British tech firm gets green light on fibroids patent
Cancer leaders pen ‘letter to the world’ calling for urgent investment
Generative AI used to create translatable paediatric care videos for LMIC hospitals
NHS Forth Valley goes live with RCPCH GrowthAPI integrated with Morse Mobile EPR
Mid and South Essex ICS building new shared care record with Orion Health
Red light can reduce blood glucose levels, study finds
- VR3 weeks ago
VR treatment for palliative care helps patients ‘flourish’ during relaxation therapy
- Features2 weeks ago
The 10 principles of good medical design
- News3 weeks ago
Top NHS doctor warns of ‘challenging’ impact of norovirus and flu
- Research1 week ago
UK study offers hope for thousands impacted each year by aggressive brain cancer